8. STOCKHOLDERS' EQUITY (DEFICIT)
|
9 Months Ended |
---|---|
Sep. 30, 2013
|
|
STOCKHOLDERS' EQUITY (DEFICIT) | |
Stockholders' Equity |
Common Stock
The Company is authorized to issue up to 190,000,000 shares of common stock (par value $0.0001). As of September 30, 2013 and December 31, 2012, the Company had 11,741,667 and 7,000,000 shares of common stock issued and outstanding, respectively. On January 29, 2013, the Company issued 900,000 shares of common stock to PhytoSPHERE in connection with the Companys acquisition of assets from PhytoSPHERE and in satisfaction of the first payment obligation to PhytoSPHERE (Note 4). On April 4, 2013, the Company issued 1,000,000 shares of common stock to PhytoSPHERE in satisfaction of its second payment obligation (Note 4). During the fiscal quarter ended June 30, 2013, the Company paid $750,000 in cash (Note 4). During the fiscal quarter ended September 30, 2013, the Company paid $200,000 in cash, and on July 23, 2013, the Company issued 1,208,334 shares of common stock and on September 20, 2013, the Company issued 1,633,333 shares of common stock to PhytoSPHERE to complete its fourth payment obligation.
Preferred Stock
The Company is authorized to issue up to 10,000,000 shares of $.0001 par value preferred stock with designations, rights and preferences to be determined from time to time by the Board. Each such series or class shall have voting powers, if any, and such preferences and/or other special rights, with such qualifications, limitations or restrictions of such preferences and/or rights as shall be stated in the resolution or resolutions providing for the issuance of such series or class of shares of preferred stock.
Options/Warrants
As of September 30, 2013 and December 31, 2012, there were no outstanding options or warrants for the purchase of the Companys common stock. On July 25, 2013, the shareholders approved the Companys 2013 Equity Incentive Plan (the Plan) which reserves 1,000,000 shares of the Companys common stock for issuance under the Plan. |